Jean Claude Desmangles
Pediatric Endocrinology · Pensacola, FLNPI 1992810048
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.2% of the total across 62 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 15.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $789 and has fallen 86.1% since, to $110 in 2025. That places this record below the midpoint for pediatric endocrinology clinicians in FL, where the typical reported total is $1,950.
Across 62 payments — averaging $32.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Insulet Corporation$319
- Dexcom, Inc.$227
- Abbott$219
- Ascendis Pharma Endocrinology Inc$115
- Lilly USA, LLC$92
- Novo Nordisk$92
- plus $950 from 19 others
Across 35 payments — averaging $3586.51 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biomarin Pharmaceutical Inc.$69K
- Boehringer Ingelheim$44K
- Boehringer Ingelheim Pharma GmbH & Co.kg$11K
- Boehringer Ingelheim France S.a.s.$996
What the payments were for
- Food & beverage$1,95897%
- Education$563%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Insulet Corporation | 6 | $319 |
| Dexcom, Inc. | 5 | $227 |
| Abbott | 2 | $219 |
| Ascendis Pharma Endocrinology Inc | 5 | $115 |
| Lilly USA, LLC | 3 | $92 |
| Novo Nordisk | 4 | $92 |
| AstraZeneca | 4 | $89 |
| Arbor Pharmaceuticals, Inc. | 5 | $80 |
| Eisai Inc. | 1 | $79 |
| Pfizer | 4 | $77 |
| Shire North American Group Inc | 1 | $71 |
| BETA Bionics, Inc. | 3 | $67 |
| Merck | 1 | $63 |
| Tolmar Pharmaceuticals, Inc. | 3 | $58 |
| Medtronic(2 entities) | 2 | $52 |
| Ipsen Biopharmaceuticals, Inc | 1 | $50 |
| Amgen | 1 | $49 |
| Tandem Diabetes Care, Inc. | 2 | $46 |
| Neurocrine Biosciences, Inc. | 2 | $45 |
| AbbVie | 2 | $39 |
| Azurity Pharmaceuticals, Inc. | 1 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Endo Pharmaceuticals Inc. | 1 | $16 |
| Eton Pharmaceuticals, Inc. | 1 | $15 |
| Ultragenyx Pharmaceutical Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FreeStyle Libre$147
How this compares
$2,014 in reported general payments places this provider in the 50th percentile of 102 pediatric endocrinology providers in Florida.
Other pediatric endocrinology in Pensacola
- Martina DrawdyPensacola$3K
- Kelly SeilerPensacola$1K
- Joshua YangOrlando$846K
- Henry RodriguezTampa$211K
- Dorothy ShulmanTampa$104K
- Michael HallerGainesville$102K
- Alejandro DiazMiami$101K
- Samuel FreedmanPembroke Pines$71K
- Jennifer MillerGainesville$57K
- Miladys Palau CollazoPort St Lucie$54K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.